These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 15996914)

  • 1. Long awaited: CD34+ determination in steady-state hematopoiesis by real-time polymerase chain reaction.
    Fruehauf S
    Haematologica; 2005 Jul; 90(7):865A. PubMed ID: 15996914
    [No Abstract]   [Full Text] [Related]  

  • 2. Progenitor cell trafficking in physiologic conditions and in myeloproliferative diseases: quantification of CD34+ cells by polymerase chain reaction.
    Oppliger Leibundgut E; Brunold C; Marti D; Horn MP; Seiler C; Schroeder V; Schmid JP; Tobler A; Zwicky C
    Haematologica; 2005 Jul; 90(7):875-80. PubMed ID: 15996924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: Selection of stem cells by using antibodies that target different CD34 epitopes yields different patterns of T-cell differentiation.
    Sutherland DR; Keeney M
    Stem Cells; 2007 Sep; 25(9):2385-6. PubMed ID: 17569789
    [No Abstract]   [Full Text] [Related]  

  • 5. A prospective randomized study on the mobilization of CD34+ cells comparing continuous intravenous vs subcutaneous administration of rhG-CSF in normal donors.
    Lee KE; Mun YC; Nam SH; Kwon JM; Lee SM; Lee MA; Yoo ES; Ahn JY; Kim JH; Seong CM
    Bone Marrow Transplant; 2005 Dec; 36(12):1027-31. PubMed ID: 16247428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. European survey of the flow cytometric determination of CD34-expressing cells.
    Serke S; Johnsen H; Huhn D; Kvalheim G
    Cytotherapy; 1999; 1(4):343-7. PubMed ID: 20426564
    [No Abstract]   [Full Text] [Related]  

  • 7. A modified polymerase chain reaction-long serial analysis of gene expression protocol identifies novel transcripts in human CD34+ bone marrow cells.
    Zhao Y; Raouf A; Kent D; Khattra J; Delaney A; Schnerch A; Asano J; McDonald H; Chan C; Jones S; Marra MA; Eaves CJ
    Stem Cells; 2007 Jul; 25(7):1681-9. PubMed ID: 17412892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNAs play a role in the development of human hematopoietic stem cells.
    Liao R; Sun J; Zhang L; Lou G; Chen M; Zhou D; Chen Z; Zhang S
    J Cell Biochem; 2008 Jun; 104(3):805-17. PubMed ID: 18189265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.
    Alegre A
    Bone Marrow Transplant; 2009 Apr; 43(8):593-5. PubMed ID: 19384344
    [No Abstract]   [Full Text] [Related]  

  • 10. The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patients.
    Lefrère F; Zohar S; Ghez D; Delarue R; Audat F; Suarez F; Hermine O; Damaj G; Maillard N; Ribeil JA; Azagury M; Misbahi R; Jondeau K; Cavazzana-Calvo M; Dal Cortivo L; Varet B
    Bone Marrow Transplant; 2006 Apr; 37(8):725-9. PubMed ID: 16518433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypermethylation of CXCR4 promoter in CD34+ cells from patients with primary myelofibrosis.
    Bogani C; Ponziani V; Guglielmelli P; Desterke C; Rosti V; Bosi A; Le Bousse-Kerdilès MC; Barosi G; Vannucchi AM;
    Stem Cells; 2008 Aug; 26(8):1920-30. PubMed ID: 18511598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of matrix metalloproteinase-9 in granulocyte colony stimulation factor-induced stem cell mobilization].
    Jin FY; Qiu LG; Li QC; Meng HX; Wang YF; Yu Z; Li Q; Han JL
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2966-70. PubMed ID: 17288807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Instrument- and protocol-dependent variation in the enumeration of CD34+ cells by flow cytometry.
    Rivadeneyra-Espínoza L; Pérez-Romano B; González-Flores A; Guzmán-García MO; Carvajal-Armora F; Ruiz-Argüelles A
    Transfusion; 2006 Apr; 46(4):530-6. PubMed ID: 16584428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations.
    Böttcher S; Ritgen M; Buske S; Gesk S; Klapper W; Hoster E; Hiddemann W; Unterhalt M; Dreyling M; Siebert R; Kneba M; Pott C;
    Haematologica; 2008 Apr; 93(4):551-9. PubMed ID: 18379010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal bone marrow hematopoietic stem cell reserves and normal stromal cell function support the use of autologous stem cell transplantation in patients with multiple sclerosis.
    Papadaki HA; Tsagournisakis M; Mastorodemos V; Pontikoglou C; Damianaki A; Pyrovolaki K; Stamatopoulos K; Fassas A; Plaitakis A; Eliopoulos GD
    Bone Marrow Transplant; 2005 Dec; 36(12):1053-63. PubMed ID: 16205726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cytochrome P450 genes in CD34+ hematopoietic stem and progenitor cells.
    Soucek P; Anzenbacher P; Skoumalová I; Dvorák M
    Stem Cells; 2005 Oct; 23(9):1417-22. PubMed ID: 16051985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A contribution to a study of apoptosis of hematopoietic stem cells CD34+ by flow cytometry before and after cryopreservation].
    Ben Nasr M; Jenhani F
    Transfus Clin Biol; 2008 Jun; 15(3):91-7. PubMed ID: 18619889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of erythrocyte lysing procedures on the recovery of hematopoietic progenitor cells in flow cytometric analysis.
    Greve B; Beller C; Cassens U; Sibrowski W; Göhde W
    Stem Cells; 2006 Mar; 24(3):793-9. PubMed ID: 16210405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.